focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 400.00
Bid: 390.00
Ask: 410.00
Change: 0.00 (0.00%)
Spread: 20.00 (5.128%)
Open: 400.00
High: 400.00
Low: 400.00
Prev. Close: 400.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Mar 2021 07:00

RNS Number : 4015R
Cropper(James) PLC
08 March 2021
 

Cropper(James) PLC

 

8 March 2021

James Cropper plc ("James Cropper" or the "Company")

Trading update

 

James Cropper PLC, the advanced materials and paper products group, is pleased to issue a positive trading update for the 52 weeks to 27 March 2021.

As reported in the half year results to 26 September 2020, the first half of the year had been particularly challenging due to the significant impact of the Covid-19 pandemic. The Group responded quickly to the challenges taking swift action to protect staff, reduce costs, optimise cash flow and protect liquidity. All divisions of the Group were affected to varying degrees by the pandemic. Since the half year, trading has improved, and the restructuring program is now complete.

In January 2021, the TFP division acquired PV3 Technologies Limited, a company specialising in the development and manufacture of electrochemical materials used in the creation of hydrogen. The acquisition is the latest step in TFP's growth plans, providing the opportunity to further enhance TFP's market position in the hydrogen economy. Following the suspension of all major capital expenditure in H1 due to the pandemic, work on installing the additional production line has now recommenced and is expected to be complete in summer of 2021.

Colourform's rate of growth has been impacted by a pandemic related downturn within the beauty and spirit sectors. Nonetheless, it is expected that revenues will be up on the previous year.

The Paper division endured the biggest impact from the pandemic as a result of global lockdowns affecting demand for luxury packaging, education and event collateral. In the first half, revenues were 45% down, compared to the comparable period last year, with the reduced demand leading to periods of inefficient or no production. Revenues in H2 have improved but expected to be 20% down compared to the comparable period last year.

The Company acted promptly at the start of the pandemic to conserve cash and implement immediate savings. It has good headroom against all its banking covenants and is in a strong financial position with liquidity of over £18 million from cash, overdraft and other available facilities including a £4m loan from the Coronavirus Large Business Interruption Loan Scheme. This is expected to be sufficient for the Company to return to more normal trading conditions, to invest and to emerge from the pandemic stronger.

Due to the improving trading performance and continued operational focus the Board expects the results for the year ending 27 March 2021 to be improved from previous expectations. The profit for the year ending 27 March 2021, before exceptional costs, is expected to be above £3.5m on sales of around £77m. This is an improvement from previous market expectations and includes around £2.9m of the Coronavirus Job Retention Scheme and Paycheck Protection Program government schemes.

This announcement contains information that would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

 

For further enquiries, please contact:

James Cropper PLC (AIM: CRPR)

Phil Wild, CEO

Isabelle Maddock, CFO

Tel: +44 (0) 1539 722002

www.jamescropper.com

 

 

Shore Capital

Robert Finlay, Henry Willcocks

John More

Tel: + 44 (0) 207 408 4050

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKPBDCBKDCNK
Date   Source Headline
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
17th Sep 201911:20 amRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSDirectors' Dealings
9th Aug 20197:00 amRNSNotification of Transaction of PDMR
8th Aug 20197:00 amRNSDirectors' Dealings
5th Aug 20197:00 amRNSDirector/PDMR Shareholding
2nd Aug 201912:27 pmRNSGrant of Awards under Long Term Incentive Plan
1st Aug 20199:30 amRNSResult of AGM
31st Jul 201911:00 amRNSAGM Statement and Trading Update
25th Jul 20197:00 amRNSDirectorate Change
22nd Jul 201912:11 pmRNSDirector/PDMR Shareholding
22nd Jul 201910:35 amRNSReplacement - Director/PDMR Shareholding
19th Jul 20198:40 amRNSDirector/PDMR Shareholding
18th Jul 201912:40 pmRNSDirector/PDMR Shareholding
17th Jul 201910:44 amRNSDirector/PDMR Shareholding
11th Jul 20198:30 amRNSDirector/PDMR Shareholding
10th Jul 20199:15 amRNSNotice of AGM and change of website address
25th Jun 20197:00 amRNSFinal Results
20th Jun 201910:02 amRNSChange of Adviser
24th May 201910:56 amRNSDirector/PDMR Shareholding
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
22nd Mar 20197:00 amRNSDirector/PDMR Shareholding
20th Mar 20197:00 amRNSDirector/PDMR Shareholding
19th Mar 20197:00 amRNSDirector/PDMR Shareholding
12th Mar 20197:00 amRNSDirector/PDMR Shareholding
1st Mar 20197:46 amRNSDirector/PDMR Shareholding
27th Feb 20197:00 amRNSDirector/PDMR Shareholding
20th Feb 20197:00 amRNSIssue of Equity
15th Feb 20197:00 amRNSDirector/PDMR Shareholding
28th Jan 201910:05 amRNSDirector/PDMR Shareholding
21st Jan 20197:00 amRNSDirector/PDMR Shareholding
14th Dec 20181:59 pmRNSDirector/PDMR Shareholding
13th Dec 20187:00 amRNSIssue of Equity and Director's Dealings
6th Dec 20187:00 amRNSDirector/PDMR Shareholding
3rd Dec 201812:37 pmRNSIssue of Equity
21st Nov 20181:03 pmRNSHolding(s) in Company
21st Nov 201810:58 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSHalf-year Report
5th Oct 20182:39 pmRNSDirector/PDMR Shareholding
1st Oct 20189:39 amRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSDirector/PDMR Shareholding
26th Sep 20187:00 amRNSIssue of Equity and PDMR Transactions
24th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20183:32 pmRNSDirector/PDMR Shareholding
18th Sep 20182:00 pmRNSTrading Update
11th Sep 20182:40 pmRNSDirector/PDMR Shareholding
20th Aug 20187:45 amRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSGrants under Long Term Incentive Plan
6th Aug 20189:41 amRNSDirector/PDMR Shareholding
3rd Aug 20189:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.